LONDON–(BUSINESS WIRE)–BenevolentAI (“BenevolentAI” or the “Firm”) (Euronext Amsterdam: BAI), a pacesetter in making use of superior AI to speed up biopharma drug discovery, will announce its interim outcomes for the six months ended 30 June 2024, on Thursday 19 September 2024. Administration will host an in-person briefing for analysts at 9:30 AM BST on the places of work of Deutsche Numis at 45 Gresham St, London EC2V 7BF, and just about by way of a webcast. A recording of the presentation shall be made obtainable
发布者：Dr.Durant，转转请注明出处：https://robotalks.cn/benevolentai-notice-of-interim-results/
